FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3199726744> ?p ?o ?g. }

• W3199726744 abstract "The present retrospective analysis sought to compare the relative diagnostic efficacy of [68Ga]Ga-DOTA-FAPI-04 to that of [18F]FDG PET/CT as a means of detecting bone metastases in patients with a range of cancer types.In total, 30 patients with bone metastases associated with different underlying malignancies were retrospectively enrolled. All patients had undergone [68Ga]Ga-DOTA-FAPI-04 and [18F]FDG PET/CT, and the McNemar test was used to compare the relative diagnostic performance of these two imaging modalities. The maximum standard uptake value (SUVmax) was used to quantify radiotracer uptake by metastatic lesions, with the relative uptake associated with these two imaging strategies being compared via the Mann-Whitney U test. The cohort was further respectively divided into two (osteolytic and osteoblastic bone metastases) and three clinical subgroups (lung cancer, thyroid cancer, and liver cancer).[68Ga]Ga-DOTA-FAPI-04 PET/CT was found to be significantly more sensitive as a means of diagnosing bone metastases relative to [18F]FDG PET/CT ([109/109] 100% vs [89/109] 81.7%; P< 0.01), consistent with the significantly increased uptake of [68Ga]Ga-DOTA-FAPI-04 by these metastatic lesions relative to that of [18F]FDG (n=109, median SUVmax, 9.1 vs. 4.5; P< 0.01). [68Ga]Ga-DOTA-FAPI-04 accumulation was significantly higher than that of [18F]FDG in both osteolytic (n=66, median SUVmax, 10.6 vs 6.1; P < 0.01), and osteoblastic metastases (n=43, median SUVmax, 7.7 vs 3.7; P < 0.01). [68Ga]Ga-DOTA-FAPI-04 uptakes were significantly higher than that of [18F]FDG in bone metastases from lung cancer (n = 62, median SUVmax, 10.7 vs 5.2; P < 0.01), thyroid cancer (n = 18, median SUVmax, 5.65 vs 2.1; P < 0.01) and liver cancer (n = 12, median SUVmax, 5.65 vs 3.05; P < 0.01). However, [68Ga]Ga-DOTA-FAPI-04 detected 10 false-positive lesions, while only 5 false-positive were visualized by [18F]FDG PET/CT.[68Ga]Ga-DOTA-FAPI-04 PET/CT exhibits excellent diagnostic performance as a means of detecting bone metastases, and is superior to [18F]FDG PET/CT in this diagnostic context. Furthermore, [68Ga]Ga-DOTA-FAPI-04 tracer uptake levels are higher than those of [18F]FDG for most bone metastases. However, owing to the potential for false-positive bone lesions, it is critical that physicians interpret all CT findings with caution to ensure diagnostic accuracy." @default.
• W3199726744 created "2021-09-27" @default.
• W3199726744 creator A5006776778 @default.
• W3199726744 creator A5012735675 @default.
• W3199726744 creator A5027624215 @default.
• W3199726744 creator A5041389247 @default.
• W3199726744 creator A5044217379 @default.
• W3199726744 creator A5044852869 @default.
• W3199726744 creator A5069522812 @default.
• W3199726744 creator A5076141593 @default.
• W3199726744 date "2021-09-17" @default.
• W3199726744 modified "2023-10-18" @default.
• W3199726744 title "Comparison of the Relative Diagnostic Performance of [68Ga]Ga-DOTA-FAPI-04 and [18F]FDG PET/CT for the Detection of Bone Metastasis in Patients With Different Cancers" @default.
• W3199726744 cites W1982701301 @default.
• W3199726744 cites W2007594814 @default.
• W3199726744 cites W2012058785 @default.
• W3199726744 cites W2022087876 @default.
• W3199726744 cites W2023392165 @default.
• W3199726744 cites W2051520294 @default.
• W3199726744 cites W2053679302 @default.
• W3199726744 cites W2064408270 @default.
• W3199726744 cites W2064736347 @default.
• W3199726744 cites W2073826159 @default.
• W3199726744 cites W2076890288 @default.
• W3199726744 cites W2102969047 @default.
• W3199726744 cites W2115201215 @default.
• W3199726744 cites W2137108848 @default.
• W3199726744 cites W2153013871 @default.
• W3199726744 cites W2283939707 @default.
• W3199726744 cites W2318698626 @default.
• W3199726744 cites W2347175105 @default.
• W3199726744 cites W2793019461 @default.
• W3199726744 cites W2796422399 @default.
• W3199726744 cites W2804845349 @default.
• W3199726744 cites W2887241162 @default.
• W3199726744 cites W2913142492 @default.
• W3199726744 cites W2917058245 @default.
• W3199726744 cites W2920956319 @default.
• W3199726744 cites W2945415599 @default.
• W3199726744 cites W2990602811 @default.
• W3199726744 cites W3014088713 @default.
• W3199726744 cites W3037555087 @default.
• W3199726744 cites W3039662551 @default.
• W3199726744 cites W3080321733 @default.
• W3199726744 cites W3083159123 @default.
• W3199726744 cites W3085246383 @default.
• W3199726744 cites W3086203434 @default.
• W3199726744 cites W3092595464 @default.
• W3199726744 cites W3102878870 @default.
• W3199726744 cites W3103762031 @default.
• W3199726744 cites W3104815767 @default.
• W3199726744 cites W3109525285 @default.
• W3199726744 cites W3110011512 @default.
• W3199726744 cites W3134514380 @default.
• W3199726744 cites W3134528863 @default.
• W3199726744 cites W3150600924 @default.
• W3199726744 cites W3165849077 @default.
• W3199726744 cites W3183807485 @default.
• W3199726744 cites W601264012 @default.
• W3199726744 cites W85734608 @default.
• W3199726744 doi "https://doi.org/10.3389/fonc.2021.737827" @default.
• W3199726744 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8484883" @default.
• W3199726744 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34604078" @default.
• W3199726744 hasPublicationYear "2021" @default.
• W3199726744 type Work @default.
• W3199726744 sameAs 3199726744 @default.
• W3199726744 citedByCount "27" @default.
• W3199726744 countsByYear W31997267442021 @default.
• W3199726744 countsByYear W31997267442022 @default.
• W3199726744 countsByYear W31997267442023 @default.
• W3199726744 crossrefType "journal-article" @default.
• W3199726744 hasAuthorship W3199726744A5006776778 @default.
• W3199726744 hasAuthorship W3199726744A5012735675 @default.
• W3199726744 hasAuthorship W3199726744A5027624215 @default.
• W3199726744 hasAuthorship W3199726744A5041389247 @default.
• W3199726744 hasAuthorship W3199726744A5044217379 @default.
• W3199726744 hasAuthorship W3199726744A5044852869 @default.
• W3199726744 hasAuthorship W3199726744A5069522812 @default.
• W3199726744 hasAuthorship W3199726744A5076141593 @default.
• W3199726744 hasBestOaLocation W31997267441 @default.
• W3199726744 hasConcept C105795698 @default.
• W3199726744 hasConcept C121608353 @default.
• W3199726744 hasConcept C126322002 @default.
• W3199726744 hasConcept C126838900 @default.
• W3199726744 hasConcept C127077266 @default.
• W3199726744 hasConcept C150903083 @default.
• W3199726744 hasConcept C186282968 @default.
• W3199726744 hasConcept C199374082 @default.
• W3199726744 hasConcept C207001950 @default.
• W3199726744 hasConcept C2775842073 @default.
• W3199726744 hasConcept C2777783956 @default.
• W3199726744 hasConcept C2779013556 @default.
• W3199726744 hasConcept C2779931791 @default.
• W3199726744 hasConcept C2989005 @default.
• W3199726744 hasConcept C33923547 @default.
• W3199726744 hasConcept C71924100 @default.
• W3199726744 hasConcept C86803240 @default.
• W3199726744 hasConceptScore W3199726744C105795698 @default.
• W3199726744 hasConceptScore W3199726744C121608353 @default.
• W3199726744 hasConceptScore W3199726744C126322002 @default.

• next